Company: IMRX
Filing Date: 2025-05-05
Form Type: 10-Q
Source: 0001790340-25-000061
Chunk: 365

Company: Immuneering Corp
Filing Date: 2025-05-05
Form: 10-Q
Item: Part I, Item 8
Chunk 365
---
865,754 

Note 5 – Property and Equipment, net

Property and equipment, net consisted of the following:March 31,2025December 31,2024Computer equipment$579,723 $570,778 Furniture and fixtures98,628 98,628 Lab equipment1,236,233 1,236,233 Leasehold improvements298,941 298,941 Total2,213,525 2,204,580 Accumulated depreciation and amortization(1,166,976)(1,081,715)Property and equipment, net$1,046,549 $1,122,865 Depreciation and amortization expense totaled $85,261 and $90,209 for the three months ended March 31, 2025 and 2024, respectively.

Note 6 – Accrued Expenses

Accrued expenses consisted of the following:March 31,2025December 31,2024Accrued professional services$309,378 $193,646 Accrued employee expenses962,338 3,583,649 Accrued research and development expenses2,042,753 1,106,872 Accrued other74,093 88,962 Total$3,388,562 $4,973,129 

Note 7 - Common Stock

The Company had 200,000,000 authorized shares of Class A common stock, $0.001 par value per share as of March 31, 2025 and December 31, 2024 of which 35,985,702 and 31,050,448 were issued and outstanding, respectively. The holders of Class A common stock are entitled one vote for each share of common stock. Dividends may be paid when, and if, 

15

declared by the Board of Directors, subject to the limitations, powers and preferences granted to the Preferred Stockholders and on a proportionate basis with holders of Class B common stock.The Company had 20,000,000 authorized shares of Class B common stock, $0.001 par value per share as of March 31, 2025 and December 31, 2024, of which no shares have been issued nor are outstanding. The holders of Class B common stock have no voting rights. Dividends may be paid when, and if, declared by the Board of Directors, subject to the limitations, powers and preferences